Syneron Medical Ltd. Announces R&D Management Transition

YOKNEAM, ISRAEL--(Marketwire - January 02, 2008) - Syneron Medical Ltd. (NASDAQ: ELOS), an innovator in the development, marketing and sales of elos™ combined-energy medical aesthetic devices, today announced the transition in the management of the R&D department from CTO, Dr. Michael Kreindel, to Dr. Boris Vaynberg who was appointed Vice President for R&D in July 2007. Dr. Kreindel will also resign his Board position.

Back to news